SS, M., MD, M., JC, L., M, Y., S, K., AR, P., . . . PJ, B. (2025). Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skipping. Molecular therapy. Nucleic acids, 36(3), 102668. https://doi.org/10.1016/j.omtn.2025.102668
Chicago Style (17th ed.) CitationSS, Maligireddy, et al. "Targeting a Pathogenic Cryptic Exon That Drives HLRCC to Induce Exon Skipping." Molecular Therapy. Nucleic Acids 36, no. 3 (2025): 102668. https://doi.org/10.1016/j.omtn.2025.102668.
MLA (9th ed.) CitationSS, Maligireddy, et al. "Targeting a Pathogenic Cryptic Exon That Drives HLRCC to Induce Exon Skipping." Molecular Therapy. Nucleic Acids, vol. 36, no. 3, 2025, p. 102668, https://doi.org/10.1016/j.omtn.2025.102668.
Warning: These citations may not always be 100% accurate.